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blood, antibiotics, etc.) Economic evaluation was based on
1997 prices. Data were compared to a pool of previously
collected variables in a larger number of German hospitals
by an independent consulting company (GEBERA).
RESULTS: Costs for endoscopic surgery were 9,428
Deutschmarks (DM) versus 10,896 DM for open surgery,
Operating room costs came to 5,091 DM for endoscopy
versus 3,986 DM for open surgery. A shorter hospital
stay of 12.7 days in comparison to 18.9 days for open
surgery contributed to the higher total costs of open sur-
gery. After endoscopic surgery, patients had higher qual-
ity-of-life scores even 6 weeks after surgery—GIQLI: 115
points versus 95 points (p  .05). Parallel results were
confirmed by the EuroQol and the SF-36 scores.
CONCLUSIONS: Laparoscopic colonic surgery is a more
cost-effective alternative to open procedures, offering a
better quality of life, but requiring highly developed sur-
gical skills.
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OBJECTIVES:
 
 In 1997, a face-to-face survey of urban
adults was conducted in the Nordic countries, Italy, the
Netherlands, Switzerland, Canada, the US, and Japan to
determine the prevalence of upper GI symptoms and im-
pact on resource consumption (physician visits, medica-
tion use, hospitalization days, workdays off) and quality
of life (QoL).
METHODS: Validation of 128 patients and 72 volunteers
yielded r
 
Internal
 
 
 
consistency
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
 
 0.6–0.9.
Questions were asked about symptoms, categorized as gas-
troesophageal reflux disease (GERD) or other upper gas-
trointestinal symptoms (UGIs), and healthcare utilization
during the previous 3 months. Quality of life was mea-
sured using the Psychological General Wellbeing Index
(PGWBI) (score 0–110) and the pertinent SF-36 questions.
RESULTS: Of 5581 responses analyzed, 500 each were
from Switzerland, Japan, and the Netherlands, and
1000 were from other countries. Results were similar
across countries. Average age was 44 years; 51% were fe-
males; 41% reported symptoms, the most common being
heartburn (36%), postprandial fullness (31%), and ab-
dominal distention (31%). There was no age effect, ex-
cept that those aged 65 had lower prevalences. More fe-
males reported UGIs (58%); males reported GERD
(52%). Symptomatic persons had 2.6 times more physi-
cian visits for any reason (1.60 versus 0.62, p  0.05),
1.5 times more prescriptions (p  0.001) and 1.7 times
more over-the-counter medications (OTCs) (p  0.001),
2.5 times more hospital days (0.55 versus 0.22, p 
0.05), and 2.2 times more days off work (4.20 versus
1.85, p  0.05). Patients averaged 0.51 physician visits
for GERD/UGIs. QoL was significantly lower in symp-
tomatic than nonsymptomatic persons for all domains.
Overall PGWBI mean (71.8 versus 85.6, p  0.01) corre-
lated with increased physician visits (p  0.001). Project-
ing annually for the US, 1 billion additional workdays
are lost, costing $100 billion (1.5% of GDP).
CONCLUSIONS: GI symptoms constitute a major health
problem with substantial health and economic impact.
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Open access services allow direct referral by primary care
doctors without an opinion from a gastroenterologist.
Our aim was to measure this new service’s effect on pre-
scribing costs. 
METHODS: The study used all patients from Tayside
who had complete prescribing data for 1 year before re-
ferral and 1 year after endoscopy and had a diagnosis re-
corded at endoscopy. The main outcome measure was the
change in prescribing costs for dispensed ulcer-healing
drugs (UHDs) in the 4 months after endoscopy compared
to the 4 months before referral.
RESULTS: Of the 1063 patients referred, 883 were resi-
dent in Tayside and had complete data. The results of en-
doscopy were normal in 311 (35%), esophagitis in 323
(37%), ulcer in 55 (6%), both in 33 (4%), and other up-
per GI pathology in 161 (18%). Significant independent
predictors of prescribing cost after endoscopy were: the
cost of drugs before referral, the diagnosis at endoscopy,
and age (p  0.0001 by both generalized linear modeling
and a nonparametric ranking test). Variables that were
not significantly associated with prescribing cost after en-
doscopy were: sex, interval between referral and endos-
copy, and previous history of either UHDs, endoscopy, or
hospitalization for GI event. Controlling for age and cost
of drugs before referral, there was a mean decrease in
prescribing costs of £11 per patient with normal endos-
copy. Prescribing costs increased by £33 for esophagitis,
by £25 for ulcer, by £41 for both, and by £23 for other
pathology.
CONCLUSIONS: Open access endoscopy was associated
with increased cost of prescribing for UHDs, mainly be-
cause the procedure revealed pathology in 65% of cases.
